Rogue gene linked to depression

By Admin
Two teams of researchers from the UK and the US have discovered that a single rouge gene is responsible for depression. They have pinpointed a region o...

Two teams of researchers from the UK and the US have discovered that a single rouge gene is responsible for depression.

They have pinpointed a region of chromosomes, known as 3p25-26, which contains up to 40 genes and they believe one or more of the genes cause the illness.

Although it has long been suspected that genetics are responsible for depression and that some people are more susceptible to it than others, the scientists are now hoping to carry some more detailed research to pinpoint the exact gene responsible.

READ MORE FROM HEALTHCARE GLOBAL:
New pill could beat stress
Study shows our brains can take 'naps'
Ibuprofen, aspirin and paracetamol stop Prozac working

While depression is often triggered by events that are out of our control such as grief, divorce or redundancy, it is hoped that these new findings will help to develop better treatments for the hard to manage condition.  

One in five Britons will suffer from depression at some point during their lifetime and according to the National Institute of National Health 16.5 percent of American adults will suffer from major depression.

Researchers from Kings College London studied more than 800 British families with at least two siblings with depression, while the US team of analysts from the Washington University Medical School in St Louis looked at 25 families in Finland and 91 in Australia.

The findings have been given increased credibility as two different studies came up with the same results.

Both sets of results have been published in the American Journal of Psychiatry and show that two people with depression who came from the same family had the same genetic variations in the 3p25-26 section on DNA.

Gerome Breen from Kings College London was one of the lead authors of the published research and he said in an interview: “In a large number of families where two or more members have depression we found robust evidence that a region called chromosome 3p25-26 is strongly linked to the disorder.”

“These findings are truly exciting as possibly for the first time we have found a genetic locus for depression.”

He added: “This breakthrough in understanding the risk for depression may get us closer to developing more effective therapies though patients should not expect to see these available for 10-15 years.”

Share

Featured Articles

Philip Morris International (PMI) in agreement with KT&G

PMI and KT&G are building a smoke-free world. In a new agreement between the two companies, smoke-free alternatives are within reach for smokers

Health tech leader Philips shares sustainability ambition

Roy Jakobs, Royal Philips CEO, says the health technology company’s sustainability impact plan will ‘enhance accountability & strengthen talent’

Automating gene therapy & pharma discovery at Automata

Sonia Jassi, Drug Discovery & Synthetic Biology Lead at Automata, explains how automation increases efficiency in gene therapy laboratories

Itai Hayut, CEO of Scopio Labs, on AI & blood cancer

Technology & AI

2023 predictions with Harshit Jain, global CEO of Doceree

Telehealth & COVID-19

Wolters Kluwer Health: health equity and telehealth

Telehealth & COVID-19